Management of Mixed-Phenotype Acute Leukemia in the East of France

Prognostic Factors and the Impact of Various Management of Acute Myeloid Leukemia in Real Life Condition

NCT03284593 ·Status: ACTIVE_NOT_RECRUITING

MultiOmic characteriZation of Acute Myeloid Leukemia Evolving From myelopRoliferative Neoplasm to Identify New Targeted Therapeutic Strategies

NCT06022341 ·Status: NOT_YET_RECRUITING ·Phase: NA

Higher Percentage of CD34+ CD38- Cells Detected by Multiparameter Flow Cytometry From Leukapheresis Products Predicts Unsustained Complete Remission in Acute Myeloid Leukemia

NCT02842112 ·Status: COMPLETED

Study of the Intermediate Metabolism in Children With Acute Lymphoblastic Leukemia (ALL)

NCT03035344 ·Status: UNKNOWN

Leukemia Cell Cultures for Research of New Anti-Cancer Therapies

NCT00993538 ·Status: UNKNOWN ·Phase: NA

Early Palliative Care for Patients With Haematological Malignancies

NCT03800095 ·Status: UNKNOWN ·Phase: PHASE3

Impact of Supportive Care on the Experience of Hospitalization of Patients Staying in the Protected Area of the Department of Blood Diseases

NCT03959007 ·Status: COMPLETED ·Phase: NA

Dependence Receptors and Leukemia

NCT03278145 ·Status: UNKNOWN

Multicenter Study of Risk-adapted Treatment for T-lineage ALL of Young Adults (18-59 Years Old)

NCT02619630 ·Status: RECRUITING ·Phase: PHASE2

Evaluation of Adverse Long-term Effects in Young Adult Survivors of Acute Leukemia

NCT02345915 ·Status: UNKNOWN ·Phase: NA

APL93: Timing of CxT and Role of Maintenance

NCT00599937 ·Status: COMPLETED ·Phase: PHASE3

PETHEMA LAL-RI/96: Treatment for Patients With Standard Risk Acute Lymphoblastic Leukemia

NCT00494897 ·Status: COMPLETED ·Phase: PHASE4

Evaluation of Advanced Practice Nurse's Management of Patients With Chronic Myeloid Leukemia

NCT06082804 ·Status: RECRUITING ·Phase: NA

Assessing Refractoriness and Infectious Survival Events in AML

NCT06709235 ·Status: COMPLETED

Investigating the Prevalence and Prognostic Importance of Polypharmacy in Adults Treated for Newly Diagnosed Acute Myelogenous Leukemia (AML)

NCT02662920 ·Status: COMPLETED

Prospective Non-interventional Study of Adult Patients With Acute Myeloid Leukemia (AML)

NCT04777916 ·Status: RECRUITING

Treatment With Low-Dose Cytarabine in Elderly Patients (Age 70 Years or Older) With Acute Myeloid Leukemia: A Single Institution Experience.

NCT03350152 ·Status: COMPLETED

A Randomized Trial Assessing the Roles of AraC in Newly Diagnosed APL Promyelocytic Leukemia (APL)

NCT00591526 ·Status: COMPLETED ·Phase: PHASE3

Program of Evaluation and Geriatric Intervention on the Functional Status, Quality of the Life, and Survival

NCT01188330 ·Status: UNKNOWN ·Phase: NA

Evaluation of Long-term Health Status and Quality of Life in Adult Survivors With Philadelphia-negative Acute Lymphoblastic Leukemia/Lymphoma Treated With an Intensive Pediatric or Pediatric-inspired Protocol

NCT04677231 ·Status: UNKNOWN

Safety and Efficacy of an Adult Acute Lymphoblastic Leukemia Chemotherapy for Adult Lymphoblastic Lymphoma

NCT00195871 ·Status: UNKNOWN ·Phase: PHASE2

Clinical Characters and Outcome of Acute Myeloid Leukemia Patients on Correlation to CD200 and CD56 Expression

NCT05512104 ·Status: UNKNOWN

Comparison of Therapies Before Stem Cell Transplantation in Patients With Higher Risk MDS and Oligoblastic AML

NCT04061239 ·Status: RECRUITING ·Phase: PHASE2

NGS in AML Relapse

NCT03582241 ·Status: UNKNOWN

Micro-transplantation in Elderly Patients With Acute Myeloid Leukemia

NCT03439371 ·Status: RECRUITING ·Phase: NA